Cargando…
BRCA1 mutation influences progesterone response in human benign mammary organoids
BACKGROUND: Women, who carry a germline BRCA1 gene mutation, have a markedly increased risk of developing breast cancer during their lifetime. While BRCA1 carriers frequently develop triple-negative, basal-like, aggressive breast tumors, hormone signaling is important in the genesis of BRCA1 mutant...
Autores principales: | Davaadelger, Batzaya, Choi, Mi-Ran, Singhal, Hari, Clare, Susan E., Khan, Seema A., Kim, J. Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878650/ https://www.ncbi.nlm.nih.gov/pubmed/31771627 http://dx.doi.org/10.1186/s13058-019-1214-0 |
Ejemplares similares
-
SUN-010 BRCA1 Mutation Influences Progesterone Response in Human Benign Mammospheres
por: Davaadelger, Batzaya, et al.
Publicado: (2019) -
Regulation of progesterone receptor signaling by BRCA1 in mammary cancer
por: Katiyar, Pragati, et al.
Publicado: (2006) -
Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland
por: Ranjan, Manish, et al.
Publicado: (2021) -
Novel Roles for P53 in the Genesis and Targeting of Tetraploid Cancer Cells
por: Davaadelger, Batzaya, et al.
Publicado: (2014) -
Two 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance
por: Shen, Hong, et al.
Publicado: (2013)